MedPath

HALOPERIDOL INJECTION

HALOPERIDOL INJECTION

Discontinued
DIN Number

02493993

Drug Class

Human

Market Date

N/A

Company
HC

neo health canada inc.

Product Information

Detailed information about this Health Canada approved drug product, including dosage form, route of administration, and regulatory classification.

Product Details

Health Canada regulatory and product classification information

Regulatory Identifiers
DIN Number02493993
AIG Number0101774001
Classification & Schedule
C
Drug Class
Human
S
Schedule
Prescription
A
ATC Code
N05AD01 HALOPERIDOL
Product Specifications
Dosage FormSolution
Route of AdministrationIntramuscular
AHFS Classification28:16.08.08
Health Canada Classification

ACTIVE INGREDIENTS (1)

HALOPERIDOLActive
Strength: 5 MG / ML
Monograph: HALOPERIDOL

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.